Annual Cash & Cash Equivalents
$218.10 M
-$49.01 M-18.35%
December 31, 2023
Summary
- As of February 8, 2025, SLRN annual cash & cash equivalents is $218.10 million, with the most recent change of -$49.01 million (-18.35%) on December 31, 2023.
- During the last 3 years, SLRN annual cash & cash equivalents has risen by +$115.86 million (+113.31%).
- SLRN annual cash & cash equivalents is now -18.35% below its all-time high of $267.11 million, reached on December 31, 2022.
Performance
SLRN Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Cash And Cash Equivalents
$216.33 M
+$88.11 M+68.73%
September 30, 2024
Summary
- As of February 8, 2025, SLRN quarterly cash and cash equivalents is $216.33 million, with the most recent change of +$88.11 million (+68.73%) on September 30, 2024.
- Over the past year, SLRN quarterly cash and cash equivalents has dropped by -$1.77 million (-0.81%).
- SLRN quarterly cash and cash equivalents is now -61.10% below its all-time high of $556.17 million, reached on June 30, 2023.
Performance
SLRN Quarterly Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash And Cash Equivalents Formula
Cash & Cash Equivalents = Cash + Short-Term Investments
SLRN Cash And Cash Equivalents Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -18.4% | -0.8% |
| 3 y3 years | +113.3% | -25.2% |
| 5 y5 years | +113.3% | -25.2% |
SLRN Cash And Cash Equivalents Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -18.4% | +113.3% | -61.1% | +68.7% |
| 5 y | 5-year | -18.4% | +113.3% | -61.1% | +68.7% |
| alltime | all time | -18.4% | +113.3% | -61.1% | +68.7% |
Acelyrin Cash And Cash Equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $216.33 M(+68.7%) |
| Jun 2024 | - | $128.21 M(-51.5%) |
| Mar 2024 | - | $264.50 M(+21.3%) |
| Dec 2023 | $218.10 M | $218.10 M(-42.9%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2023 | - | $381.74 M(-31.4%) |
| Jun 2023 | - | $556.17 M(+92.3%) |
| Mar 2023 | - | $289.19 M(+8.3%) |
| Dec 2022 | $267.11 M(+161.3%) | $267.11 M |
| Dec 2021 | $102.24 M | - |
FAQ
- What is Acelyrin annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for Acelyrin?
- What is Acelyrin annual cash & cash equivalents year-on-year change?
- What is Acelyrin quarterly cash and cash equivalents?
- What is the all time high quarterly cash and cash equivalents for Acelyrin?
- What is Acelyrin quarterly cash and cash equivalents year-on-year change?
What is Acelyrin annual cash & cash equivalents?
The current annual cash & cash equivalents of SLRN is $218.10 M
What is the all time high annual cash & cash equivalents for Acelyrin?
Acelyrin all-time high annual cash & cash equivalents is $267.11 M
What is Acelyrin annual cash & cash equivalents year-on-year change?
Over the past year, SLRN annual cash & cash equivalents has changed by -$49.01 M (-18.35%)
What is Acelyrin quarterly cash and cash equivalents?
The current quarterly cash and cash equivalents of SLRN is $216.33 M
What is the all time high quarterly cash and cash equivalents for Acelyrin?
Acelyrin all-time high quarterly cash and cash equivalents is $556.17 M
What is Acelyrin quarterly cash and cash equivalents year-on-year change?
Over the past year, SLRN quarterly cash and cash equivalents has changed by -$1.77 M (-0.81%)